Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL11736752 | 0.95 | CA1 (0.90) | — | |
| Acetic Acid SCHEMBL28032096 | 0.95 | CA1 (0.90) | — | |
| Acetic Acid SCHEMBL5705621 | 0.95 | CA1 (0.90) | — | |
| Acetic Acid SCHEMBL2805390 | 0.95 | — | — | |
| Acetic Acid SCHEMBL19745013 | 0.95 | CA1 (0.90) | — | |
| Acetic Acid SCHEMBL901119 | 0.95 | — | — | |
| Acetic Acid SCHEMBL28646773 | 0.91 | CA1 (0.73) | — | |
| Acetic Acid SCHEMBL31186945 | 0.91 | — | — | |
| Acetic Acid SCHEMBL8000761 | 0.91 | — | — | |
| Acetic Acid SCHEMBL28146356 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116410294-A | Preparation and purification method of monopolyethylene glycol recombinant human erythropoietin | 华润昂德生物药业有限公司 | 2023-07-11 | — | — | CN | claimed |
| CN-105541856-B | The method that sanguinarine and Chelerythrine are extracted using chromatographic technique | 利穗科技(苏州)有限公司 | 2018-01-09 | — | — | CN | claimed |
| CN-104787835-B | Chromatographic technique is utilized to extract the method for cefixime fine work in industrial wastes | 利穗科技(苏州)有限公司 | 2016-09-14 | — | — | CN | claimed |
| CN-105001305-A | Method for extracting high-purity daptomycin by utilizing chromatographic technique | LISURE SCIENCE SUZHOU CO LTD | 2015-10-28 | — | — | CN | claimed |
| CN-104787835-A | Method for extracting cefixime refined product in industrial waste liquor by utilizing chromatographic technique | LISURE SCIENCE SUZHOU CO LTD | 2015-07-22 | — | — | CN | claimed |
| CN-102520041-B | Method for preparing amino functional multiporous silica-based composite material for ion detection | UNIV KUNMING SCIENCE & TECHNOLOGY | 2014-07-30 | — | — | CN | claimed |
| CN-102520041-A | Method for preparing amino functional multiporous silica-based composite material for ion detection | UNIV KUNMING SCIENCE & TECHNOLOGY | 2012-06-27 | — | — | CN | claimed |
| CN-117074572-A | Method for detecting related substances of 1, 4-dimethyl-7-isopropyl azulene-3-sodium sulfonate and related preparations thereof | 成都阿奇生物医药科技有限公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-116410294-A | Preparation and purification method of monopolyethylene glycol recombinant human erythropoietin | 华润昂德生物药业有限公司 | 2023-07-11 | — | — | CN | disclosed |
| CN-113548875-B | Oyster shell ceramic partition and preparation process and application thereof | 烟台大学 | 2022-06-28 | — | — | CN | disclosed |
| CN-108079311-A | For the nucleophilic catalyst that oxime is bonded | 百深有限责任公司 | 2018-05-29 | — | — | CN | disclosed |
| CN-108079312-A | For the nucleophilic catalyst that oxime is bonded | 百深有限责任公司 | 2018-05-29 | — | — | CN | disclosed |
| CN-108078876-A | Hydrogel comprising snake venom polypeptide and the maintenance eye mask prepared by the hydrogel | 广州市暨达生物科技有限公司 | 2018-05-29 | — | — | CN | disclosed |
| WO-2003033673-A2 | HIGH-THROUGHPUT TRANSCRIPTOME AND FUNCTIONAL VALIDATION ANALYSIS | AGY THERAPEUTICS, INC. (US) | 2003-04-24 | — | — | WO | disclosed |
| US-20030027168-A1 | Generation of preferential nucleotide sequence; obtain complimentary nucleotide sequences, incubate with primers, amplify, recover nucleotide sequences | AGY THERAPEUTICS, INC. (US) | 2003-02-06 | — | — | US | disclosed |
| CN-1169114-A | Sequestration agents | CORTECS LTD (GB) | 1997-12-31 | — | — | CN | disclosed |
| CN-1137751-A | Hydrophobic formulations | CORTECS LTD (GB) | 1996-12-11 | — | — | CN | disclosed |
| US-4180499-A | ISOLATION | HOFFMANN-LA ROCHE INC. (US) | 1979-12-25 | — | — | US | disclosed |
| US-4086217-A | CHROMATOGRAPHY | HOFFMANN-LA ROCHE INC. (US) | 1978-04-25 | — | — | US | disclosed |
| US-3956258-A | SEPARATION, DIALYSIS, CHROMATOGRAPHY | HOFFMANN-LA ROCHE INC. (US) | 1976-05-11 | — | — | US | disclosed |